Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses.
Fratzke AP, Jan S, Felgner J, Liang L, Nakajima R, Jasinskas A, Manna S, Nihesh FN, Maiti S, Albin TJ, Esser-Kahn AP, Davies DH, Samuel JE, Felgner PL, Gregory AE. Fratzke AP, et al. Among authors: jan s. Front Immunol. 2021 Mar 17;12:653092. doi: 10.3389/fimmu.2021.653092. eCollection 2021. Front Immunol. 2021. PMID: 33815413 Free PMC article.
Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components.
Hernandez-Davies JE, Felgner J, Strohmeier S, Pone EJ, Jain A, Jan S, Nakajima R, Jasinskas A, Strahsburger E, Krammer F, Felgner PL, Davies DH. Hernandez-Davies JE, et al. Among authors: jan s. Front Immunol. 2021 Jul 14;12:692151. doi: 10.3389/fimmu.2021.692151. eCollection 2021. Front Immunol. 2021. PMID: 34335601 Free PMC article.
Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants.
Hernandez-Davies JE, Dollinger EP, Pone EJ, Felgner J, Liang L, Strohmeier S, Jan S, Albin TJ, Jain A, Nakajima R, Jasinskas A, Krammer F, Esser-Kahn A, Felgner PL, Nie Q, Davies DH. Hernandez-Davies JE, et al. Among authors: jan s. Sci Rep. 2022 Jun 2;12(1):9198. doi: 10.1038/s41598-022-12727-y. Sci Rep. 2022. PMID: 35654904 Free PMC article.
Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine.
Ramirez A, Felgner J, Jain A, Jan S, Albin TJ, Badten AJ, Gregory AE, Nakajima R, Jasinskas A, Felgner PL, Burkhardt AM, Davies DH, Wang SW. Ramirez A, et al. Among authors: jan s. Bioconjug Chem. 2023 Sep 20;34(9):1653-1666. doi: 10.1021/acs.bioconjchem.3c00317. Epub 2023 Sep 8. Bioconjug Chem. 2023. PMID: 37682243 Free PMC article.
Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines.
Felgner J, Clarke E, Hernandez-Davies JE, Jan S, Wirchnianski AS, Jain A, Nakajima R, Jasinskas A, Strahsburger E, Chandran K, Bradfute S, Davies DH. Felgner J, et al. Among authors: jan s. Antiviral Res. 2024 May;225:105851. doi: 10.1016/j.antiviral.2024.105851. Epub 2024 Mar 7. Antiviral Res. 2024. PMID: 38458540 Free article.
Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase.
Ma CI, Tirtorahardjo JA, Jan S, Schweizer SS, Rosario SAC, Du Y, Zhang JJ, Morrissette NS, Andrade RM. Ma CI, et al. Among authors: jan s. Front Cell Infect Microbiol. 2021 Mar 19;11:618994. doi: 10.3389/fcimb.2021.618994. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816332 Free PMC article.
1,103 results